Bt Brinjal

Bt brinjal is a transgenic variety of eggplant (Solanum melongena) into which scientists inserted the cry1Ac gene derived from the soil bacterium Bacillus thuringiensis, enabling the plant to synthesise an endotoxin that kills the brinjal fruit and shoot borer (Leucinodes orbonalis), a pest responsible for substantial yield losses across South Asia. The variety was developed in India by the Maharashtra Hybrid Seeds Company (Mahyco) in collaboration with Monsanto, with public-sector partners including the University of Agricultural Sciences, Dharwad, and Tamil Nadu Agricultural University. Regulatory authority over such genetically modified organisms in India flows from the Environment (Protection) Act, 1986, and specifically the "Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms, Genetically Engineered Organisms or Cells, 1989," which vest clearance powers in the Genetic Engineering Appraisal Committee (GEAC), housed under the Ministry of Environment, Forest and Climate Change.

The procedural pathway for any GM crop in India is sequential and multi-tiered. An applicant first conducts laboratory and contained greenhouse research overseen by the Institutional Biosafety Committee (IBSC) and the Review Committee on Genetic Manipulation (RCGM) under the Department of Biotechnology. Upon satisfactory contained trials, the developer seeks approval for confined open-field "biosafety research level" trials, which generate data on toxicity, allergenicity, gene flow, and effects on non-target organisms. The GEAC, as the apex body, evaluates this dossier and is empowered to grant or refuse environmental release for commercial cultivation. For Bt brinjal, Mahyco submitted its biosafety data, and an Expert Committee (EC-II) constituted by the GEAC reviewed it, recommending commercialisation in October 2009.

The clearance, however, triggered an extraordinary intervention. Because brinjal is a directly consumed food crop and India is a centre of its genetic diversity—home to thousands of indigenous landraces—the prospect of commercial release provoked widespread scientific, agronomic, and civil-society opposition. The then Minister of Environment and Forests, Jairam Ramesh, conducted a series of seven public consultations across major brinjal-growing states between January and February 2010. On 9 February 2010, he announced an indefinite moratorium on the commercial release of Bt brinjal, citing the absence of independent long-term biosafety studies, the precautionary principle, and the lack of public and scientific consensus. The moratorium did not constitute an outright ban but suspended release pending further independent testing and the establishment of a credible, autonomous regulatory body.

The decision reverberated across capitals and ministries. The Indian moratorium remains in force as of the present, making Bt cotton—approved by the GEAC in 2002—India's only commercially cultivated GM crop. Neighbouring Bangladesh, by contrast, approved four Bt brinjal varieties for commercial cultivation in October 2013, with field planting beginning in 2014 under the Bangladesh Agricultural Research Institute, drawing on the same Mahyco event shared through a USAID-supported, Cornell-coordinated initiative. The Philippines also pursued Bt eggplant trials, and its Supreme Court briefly halted them in 2015 before regulatory frameworks were reconstituted. India's Supreme Court, meanwhile, heard the long-running Aruna Rodrigues v. Union of India public interest litigation, in which a Technical Expert Committee submitted reports in 2012–2013 recommending caution on environmental release of GM food crops.

Bt brinjal must be distinguished from Bt cotton, the adjacent and frequently conflated concept. Bt cotton is a fibre and oilseed crop, not a directly consumed vegetable, and its 2002 approval set the precedent that the food-crop status of brinjal subsequently complicated. It is equally distinct from GM mustard (DMH-11), a herbicide-tolerant hybrid developed by Delhi University's Centre for Genetic Manipulation of Crop Plants, which the GEAC recommended for environmental release in 2017 and again in 2022, and which is the subject of separate ongoing litigation. The brinjal case is also conceptually separate from gene-edited crops produced via CRISPR techniques, which the Indian government exempted from certain GEAC rules in 2022 where no foreign DNA is introduced (SDN-1 and SDN-2 categories).

Controversy surrounding Bt brinjal centres on several contested edge cases. Critics, including the coalition of scientists who signed open letters to the Prime Minister, alleged that the original biosafety dossier relied substantially on data generated by the developer rather than independent institutions, raising conflict-of-interest concerns. The episode catalysed demands for the long-pending Biotechnology Regulatory Authority of India (BRAI) Bill, introduced in 2013 to create a single statutory regulator, though the bill lapsed and was never enacted. Allegations of unauthorised cultivation of Bt brinjal in Haryana surfaced in 2019, prompting investigations into illegal seed diffusion. Proponents counter that Bangladesh's adoption has reduced pesticide application and raised smallholder incomes, citing field studies, while opponents dispute the methodology of those assessments.

For the working practitioner, Bt brinjal is a touchstone case in the politics of agricultural biotechnology, regulatory federalism, and the precautionary principle as applied to food sovereignty. It illustrates how a scientifically cleared technology can be halted by executive discretion grounded in public consultation, and how India's stance diverges from that of its South Asian neighbours despite shared germplasm. UPSC General Studies Paper III candidates encounter it as an exemplar of the tension between biotechnology-driven productivity and biosafety, intellectual property, and the role of GEAC. Desk officers and policy analysts tracking India's evolving GM framework—including the GM mustard litigation and gene-editing exemptions—treat the 2010 moratorium as the reference point against which all subsequent food-crop biotechnology decisions are measured.